Evidence map›Paper›PMID 28599420›Full record

ArticleOncology letters2017

Gene and miRNA expression profiles of mouse Lewis lung carcinoma LLC1 cells following single or fractionated dose irradiation.

Vaidotas Stankevicius, Karolina Kuodyte, Diana Schveigert, Danute Bulotiene, Tomas Paulauskas, Kristina Daniunaite, Kestutis Suziedelis

Abstract read
In one paragraph

Article in Oncology letters, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Cell Therapy with Human Reprogrammed CD8International journal of molecular sciences · 2022
    Article
  4. Article
  5. Radiation-induced Adaptive Response: New Potential for Cancer Treatment.Clinical cancer research : an official journal of the American Association for Cancer Research · 2020
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Vaidotas StankeviciusLaboratory of Molecular Oncology, National Cancer Institute, LT-08660 Vilnius, Lithuania.
Karolina KuodyteLaboratory of Molecular Oncology, National Cancer Institute, LT-08660 Vilnius, Lithuania.
Diana SchveigertLaboratory of Molecular Oncology, National Cancer Institute, LT-08660 Vilnius, Lithuania.
Danute BulotieneLaboratory of Biomedical Physics, National Cancer Institute, LT-08660 Vilnius, Lithuania.
Tomas PaulauskasInstitute of Biosciences, Life Sciences Center, Vilnius University, LT-10224 Vilnius, Lithuania.
Kristina DaniunaiteInstitute of Biosciences, Life Sciences Center, Vilnius University, LT-10224 Vilnius, Lithuania.
Kestutis SuziedelisLaboratory of Molecular Oncology, National Cancer Institute, LT-08660 Vilnius, Lithuania.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In clinical practice ionizing radiation (IR) is primarily applied to cancer treatment in the form of fractionated dose (FD) irradiation. Despite this fact, a substantially higher amount of current knowledge in the field of radiobiology comes from

Indexed as

fractionated irradiationgene and microRNA expressiongenome-wide expression analysisLewis lung carcinomaradiation responsesyngeneic tumor model

Identifiers

PMID28599420
PMCPMC5453008

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.